Prostate Cancer Recurrent Clinical Trials

51 clinical trials for Prostate Cancer Recurrent across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy — RECRUITING · PHASE2
Social, Structural, and Lifestyle Drivers of Prostate Cancer Disparities — RECRUITING
Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era — RECRUITING · NA
COAST Therapy in Advanced Solid Tumors and Prostate Cancer — RECRUITING · PHASE1
Lab Research Using Mini-tumors to Study Prostate Cancer Treatments — RECRUITING
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors — RECRUITING · PHASE1
Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy — RECRUITING
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer — RECRUITING · PHASE3
Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer — RECRUITING · PHASE1
PSMA-RLT in Biochemically Recurrent PCa — RECRUITING · PHASE2
PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE — RECRUITING
Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFU — NOT_YET_RECRUITING · PHASE4
Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer — NOT_YET_RECRUITING · PHASE2
An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum — COMPLETED
A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer — COMPLETED · PHASE2
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE3
Phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC 1 in men with biochemical recurrence of prostate cancer — TERMINATED · PHASE1
18F-PSMA PET/CT Versus CT Alone in Assessment of Prostatic Cancer Patients — NOT_YET_RECRUITING
HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer — TERMINATED · PHASE1
Post-radiation Prostate Cancer Local Recurrences: Detection With Histoscanning™ and MRI — COMPLETED · NA
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer — COMPLETED · PHASE3
PET-MR-PSA Prostate Cancer Recidive Study — ACTIVE_NOT_RECRUITING
Salvage Lymph Node Dissection in Prostate Cancer Patients With Recurrence After Radical Prostatectomy — COMPLETED · NA
Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer — COMPLETED · PHASE2
A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment — NOT_YET_RECRUITING · PHASE3
Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer — COMPLETED · PHASE1
Pilot Study of Whole Gland Salvage HDR Prostate Brachytherapy for Locally Recurrent Prostate Cancer — ACTIVE_NOT_RECRUITING · NA
Using Meditation for Oncology Anxiety — WITHDRAWN · NA
Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer — OTHER · PHASE2
Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer. — COMPLETED · PHASE3
Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence — COMPLETED · PHASE2
Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer — TERMINATED
Identification of Predictive Biomarkers — COMPLETED · NA
Molecular Profiling in Prostate Cancer — OTHER
Metformin Prostate Cancer Adjuvant Trial — COMPLETED · PHASE2
Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE1
Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer — OTHER
Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE2
F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence — COMPLETED · PHASE3
Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer — COMPLETED · PHASE3
Study of 68Ga-HBED-PSMA PET/CT and Conventional Imaging in Occult Biological Relapse Prostate Cancer — COMPLETED · NA
MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer — OTHER · PHASE2
Sipuleucel-T and Low-protein Diet in Patients With Metastatic Castrate-resistant Prostate Cancer — COMPLETED · NA
A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer — OTHER · PHASE3
Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer — OTHER
F18-PSMA-1007 PET for Early Biochemical Recurrence of Prostate Cancer — OTHER · NA
The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer — COMPLETED · NA
Firmagon (Degarelix) Intermittent Therapy — TERMINATED · PHASE4
SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience — COMPLETED
Evaluation of the Metastasis and Recurrence of Prostate Cancer — OTHER

Refine this search